Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SYX-5219 skin immune response study in atopic dermatitis
NL-OMON58898Phase 1Completed
- Sponsor
- Sitryx
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1 trial of SYX-5219 in atopic dermatitis (AD), sponsored by Sitryx. Started Nov 2025; status: completed.
02
Drugs
SYX-5219
03
Conditions
atopic dermatitis (AD)
Beyond the preview
Go deeper on NL-OMON58898.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON58898.